With investor worries over higher rates pushed to the backburner, the portfolios all posted respectable gains. The Growth Portfolio led the pack, gaining 2.8%, handily outpacing its benchmark thanks to strong showings from the Renaissance Global Healthcare Fund, Trimark U.S. Small Companies Fund, and the Mackenzie Ivy Foreign Equity Fund. Year to date, the portfolio is up more than 15%.
At the other end of the risk scale, our Conservative Portfolio gained 1%, doubling the return of its benchmark. It was again the Ivy Foreign Equity and healthcare fund that were the biggest contributor to its outperformance. So far this year, the portfolio has gained more than 4%.
The portfolios continue to deliver risk adjusted returns that are significantly stronger than their respective benchmarks. Their absolute return levels are well within our expected ranges based on the risk reward profile of each portfolio.
You can download our detailed Portfolio Review here.
Portfolio Performance (July 31, 2013)
| 1 Mth | 3 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 5 Yr | 10 Yr | ||
|---|---|---|---|---|---|---|---|---|---|
| Conservative | 1.0% | -0.5% | 4.3% | 6.5% | 4.6% | 5.8% | 5.3% | 5.8% | |
| Moderate Balanced | 1.4% | 1.0% | 7.2% | 10.0% | 5.3% | 6.5% | 5.0% | 5.9% | |
| Balanced | 1.7% | 1.6% | 8.3% | 11.5% | 5.5% | 6.9% | 4.8% | 6.3% | |
| Balanced Growth | 2.2% | 3.4% | 11.8% | 15.6% | 6.9% | 7.8% | 4.3% | 6.4% | |
| Growth Portfolio | 2.8% | 5.3% | 15.3% | 19.8% | 9.1% | 10.3% | 4.5% | 6.9% |